We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


OGT and Integrated Genomics to Develop a Pichia Pastoris Gene Expression Microarray

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "OGT and Integrated Genomics to Develop a Pichia Pastoris Gene Expression Microarray"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Oxford Gene Technology (OGT) and Integrated Genomics (IG) have announced the signing of a collaboration to develop and market a Pichia pastoris Gene Expression (GE) oligonucleotide microarray.

The collaboration gives OGT access to IG’s proprietary Pichia pastoris genomic sequence for the design and development of a high quality optimised 60 mer oligonucleotide microarray using the ink jet in-situ synthesis (IJISS) platform. OGT will market the array worldwide, and offer a sample analysis service at its Oxford laboratory.

Mr James Clough, Commercial Director at OGT said: “We are delighted to be working with Integrated Genomics. The combination of OGT’s oligonucleotide array expertise combined with Integrated Genomics sequence and detailed Pichia genome annotations will be a powerful molecular research tool for the Pichia community and add strength to our growing portfolio.”

Dr Theresa Walunas, Vice President of Integrated Genomics added: “OGT’s IJISS technology provides an important new capability to the Pichia research community. Microarrays will allow researchers to understand how Pichia’s gene expression changes in response to genetic modifications.”